✦ LIBER ✦

Deficiency of neutrophilic granule membrane glycoproteins in the myelodysplastic syndromes: A common deficiency in 216 patients studied by the cancer and leukemia group B

✍ Scribed by M.Tarek Elghetany; Bercedis Peterson; Jane MacCallum; Douglas A. Nelson; Judy F. Varney; Arthur K. Sullivan; Lewis R. Silverman; Charles A. Schiffer; Frederick R. Davey; Clara D. Bloomfield

Book ID: 114119136
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 661 KB
Volume: 21
Category: Article
ISSN: 0145-2126
DOI: 10.1016/s0145-2126(97)00053-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Controlled Trial of Azacitidi

Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B

✍ Silverman, L. R. 📂 Article 📅 2002 🏛 American Society of Clinical Oncology 🌐 English ⚖ 185 KB

A phase II study of the oral VEGF recept

A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance)

✍ Gupta, Pankaj; Mulkey, Flora; Hasserjian, Robert P.; Sanford, Ben L.; Vij, Ravi; 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 204 KB

P-403 Vatalanib in patients with previou

P-403 Vatalanib in patients with previously untreated advanced malignant mesothelioma (MM): Preliminary analysis of a phase II study by the Cancer and Leukemia Group B (CALGB 30107)

✍ Jahan, T.; Gu, L.; Wang, X.; Kratzke, R.; Green, M.; Vokes, E.; Kindler, H. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB